According to Future Market Insights, the airlift bioreactor market is estimated to secure a valuation of US$ 2.4 billion in 2023 and is estimated to rise to US$ 6.9 billion by 2033. The market is anticipated at a CAGR of 11.2% during the forecast period. The factors accelerating the demand for airlift bioreactors are as follows
Increased R&D activities in the biotechnology sector
The rapidly growing biopharmaceutical industry
The growth of the biotechnology and pharmaceuticalindustries
Increased demand for single-use bioreactors
Increased number of clinical and preclinical trials performed
North America dominates the airlift bioreactor market during the forecast period
The increased application of airlift bioreactors in the biotechnology industry and pharmaceutical industry to produce biological products, antibodies, and vaccines is likely to boost the airlift bioreactor market sales during the forecast period. Also, the increased use of single-use bioreactors is expected to drive market growth during the forecast period.
Data Points
Key Statistics
Expected Market Value in 2023
US$ 2.4 billion
Projected Market Value in 2033
US$ 6.9 billion
Growth Rate (2023 to 2033)
CAGR of 11.2%
With the growing pharmaceutical industry, the airlift bioreactor market is expected to grow. Increased demand for personalized medicines is expected to increase the airlift bioreactors market growth. With the increased production of monoclonal antibodies, there has been a surge in demand for airlift bioreactors in the biopharmaceutical industry.
The airlift bioreactor market is expected to witness a significant rise over the forecast period owing to technological advances in healthcare. The increased research activity in the biochemical and growing production of different biochemical is likely to provide lucrative opportunities for market growth.
North America dominates the airlift bioreactors market during the forecast period owing to the increased R&D activities in pharmaceuticals. Also, the presence of well-established biopharmaceutical companies and key operating players in the region is likely to drive market growth in North America.
Europe is expected to provide a lucrative opportunity for airlift bioreactor market growth during the forecast period due to the increased prevalence of chronic disorders and the increased rate of rare diseases in the region.
The airlift bioreactor market in Asia-Pacific is estimated to grow with the fastest CAGR during the forecast period. Expansion of the biopharmaceutical industry is primarily contributing to the market growth in the region.
Sartorius AG, Lonza, Shree Biocare, Knik Technology, Electrolab Biotech, Rotech Inc, Cellexus, Solida Biotech GmBH, Zeta GmBH, Kuhner Shaker are some of the key players operating in the airlift bioreactor market
The airlift bioreactor market is highly fragmented with the presence of many large and small-scale players. The major players in the airlift bioreactor market are focusing on strategies like mergers, acquisitions, and partnerships to increase their brand presence. Also, the leading players are focusing on innovation to develop innovative specialty control plasma. Following are some of the developments in the market.
In March 2022- Zeta opened its new subsidiary in Singapore, Asian companies in pharmaceutical and biotechnology can benefit from customer-specific service
The demand for airlift bioreactors is expected to flourish during the forecast period owing to rising demand from the biotechnology and pharmaceutical industry. Also, the advances in technology and growing investments in healthcare boost the growth of the airlift bioreactors market. Start-ups are entering the airlift bioreactors market with innovative products designed for high-density cell culture and the production of various products to fulfill the increased demand for the product.
Founded in 2001, Krishna scientific supplier is the Manufacturer, Supplier & Exporter of a wide range of BIOREACTORS which include Stainless Steel Bioreactor such as Industrial Bioreactors, Bioreactor, Glass Bioreactor, Laboratory Bioreactors, and Stainless Steel Bioreactors.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Airlift Bioreactors Market Overview
According to the latest research by Future Market Insights, the airlift bioreactor market is set to witness positive growth of CAGR 11% during 2021-2031. The global airlift bioreactors market is expected to be driven by increased research and development for the production of different biochemicals.
Airlift bioreactors are a type of bioreactor in which mixing of the content happens pneumatically using gas. These are used instead of stirred tank bioreactors where mechanical agitation and moving parts are required.
The absence of moving parts reduces the risk of contamination in airlift bioreactors. Hence, making them desirable for the growth of microorganisms. Also, these reactors offer certain advantages over other bioreactors like being more energy efficient and having a less harsh hydrodynamic environment.
What is Driving Demand for Airlift Bioreactors Market?
Airlift bioreactors are used for the production of different biopharmaceuticals products like monoclonal antibodies. These monoclonal antibodies are used for the treatment of many diseases and cancers.
They are also helpful to fight against viruses like SARS-CoV-2. Currently, there is an increase in demand for these products and is expected to increase in the next few years due to the increasing prevalence of viral diseases.
To meet this demand, the companies are investing in building their infrastructure and equipment base. This will drive the market. The airlift bioreactors are also used for vaccine production. The impact of COVID-19 on a global scale has been tremendous. To fight against this deadly virus, vaccines are being manufactured on a large scale. Airlift reactors being a major component of the vaccine producing process, there has been an upsurge in the demand for them in the biopharmaceutical industry in the past two years.
Another driving factor for airlift bioreactors is increasing drug discovery and increasing preference for biologics and biopharma etc. Hence, the demand for medicines will increase and will drive the market.
The other driver for the market is the increase in chronic diseases like cancer, diabetes, heart disease, chronic lung disease etc. According to CDC, in the US 6 out of 10 adults suffer from a chronic disease and this is expected to increase in future. There has been a surge in the research for cancer treatment. This may act as a driver for the market.
The airlift bioreactor market has many large-scale players available in worldwide markets, and various small-scale participants in specific regional markets like Asia. The growth of the players is mainly focused on various acquisitions and partnerships.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Key segments
By Product:
Internal airlift loop bioreactor
External airlift loop bioreactor
By Capacity:
5L
7L
10L
30L
By Material:
Stainless steel
Glass
By Usage:
Single-use / disposal
Reusable
By Production Scale:
Laboratory scale
Pilot-scale
Large scale
By End-User:
Biopharmaceutical companies
Contract research organizations (CROs)/ Contract development and manufacturing organizations (CDMOs)
Research and development companies
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
